Hyaluronic Acid
CAS 9004-61-9
Hyaluronic Acid (CAS 9004-61-9) is a pharmaceutical compound with 0 bioactivity targets and 445 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Sensitisation | 82 | 345.179 | 10070834 |
| Polycystic ovaries | 82 | 327.744 | 10036049 |
| Rhinitis allergic | 88 | 253.351 | 10039085 |
| Ejection fraction | 58 | 243.425 | 10050527 |
| Blood test abnormal | 84 | 202.552 | 10061016 |
| Carpal tunnel syndrome | 86 | 199.534 | 10007697 |
| Sleep disorder due to a general medical condition | 80 | 199.382 | 10063910 |
| Ejection fraction abnormal | 47 | 182.044 | 10014331 |
| Toxic anterior segment syndrome | 47 | 174.776 | 10066366 |
| Burning sensation | 108 | 168.048 | 10006784 |
| Keratopathy | 38 | 154.596 | 10023365 |
| Hypothyroidism | 96 | 148.892 | 10021114 |
| Nephrectomy | 36 | 134.925 | 10029116 |
| Sleep apnoea syndrome | 81 | 132.344 | 10040979 |
| Renal disorder | 83 | 123.934 | 10038428 |
| Cardiac disorder | 95 | 113.099 | 10061024 |
| Retinal vasculitis | 26 | 99.348 | 10038905 |
| Fibromyalgia | 84 | 96.123 | 10048439 |
| Product preparation error | 38 | 90.775 | 10076869 |
| Gastrooesophageal reflux disease | 97 | 87.962 | 10017885 |
| Corneal opacity | 21 | 77.524 | 10011035 |
| Asthma | 98 | 70.565 | 10003553 |
| Wheezing | 82 | 60.452 | 10047924 |
| Eye swelling | 41 | 55.834 | 10015967 |
| Eyelid ptosis | 29 | 54.957 | 10015995 |
| Therapeutic product effect incomplete | 90 | 54.649 | 10082200 |
| Loss of personal independence in daily activities | 76 | 53.813 | 10079487 |
| Glaucoma | 35 | 49.82 | 10018304 |
| Cataract | 58 | 49.755 | 10007739 |
| Swelling face | 57 | 48.35 | 10042682 |
| Full blood count abnormal | 45 | 47.961 | 10017412 |
| Corneal erosion | 11 | 45.422 | 10011013 |
| Vision blurred | 71 | 45.092 | 10047513 |
| Iris hypopigmentation | 8 | 44.854 | 10063694 |
| Endophthalmitis | 21 | 42.129 | 10014801 |
| Headache | 210 | 39.087 | 10019211 |
| Ocular pemphigoid | 8 | 37.254 | 10067776 |
| Eye pain | 39 | 37.232 | 10015958 |
| Visual acuity reduced | 34 | 37.131 | 10047531 |
| Facial paresis | 17 | 34.84 | 10051267 |
| Brow ptosis | 8 | 33.796 | 10059001 |
| Corneal oedema | 13 | 32.764 | 10011033 |
| Eye inflammation | 18 | 32.503 | 10015943 |
| Facial pain | 21 | 31.868 | 10016059 |
| Facial asymmetry | 10 | 30.9 | 10068737 |
| Hypertension | 120 | 29.528 | 10020772 |
| Drug intolerance | 7 | 29.361 | 10061822 |
| Strabismus | 13 | 28.914 | 10042159 |
| Off label use | 260 | 28.834 | 10053762 |
| Blindness | 31 | 28.761 | 10005169 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| HYALURONIC ACID | 5463 | SU | MTHSPL |
| hyaluronic acid | 5463 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Hyaluronic Acid used for in pharmaceutical contexts?
Hyaluronic Acid (CAS 9004-61-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Hyaluronic Acid?
Hyaluronic Acid has 445 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Sensitisation, Polycystic ovaries, Rhinitis allergic, Ejection fraction, Blood test abnormal. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Hyaluronic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Hyaluronic Acid with EU status "permitted".
What clinical phase is Hyaluronic Acid in?
No phase 1-4 clinical development badge is rendered for Hyaluronic Acid because the matched compound identifier rows do not contain a max-phase value.